We are live on ! Find out more
AC

Alexandria Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+7.43%
1 Year Est. Return
+29.48%
3 Year Est. Return
+66.81%
5 Year Est. Return
+127.84%
10 Year Est. Return
AUM
$686M
AUM Growth
+$289M
Cap. Flow
+$256M
Cap. Flow %
37.28%
Top 10 Hldgs %
23.94%
Holding
625
New
44
Increased
123
Reduced
47
Closed
391

Sector Composition

Rank Sector Weight
1 Technology 13.34%
2 Healthcare 11.51%
3 Financials 9.38%
4 Consumer Discretionary 8.29%
5 Communication Services 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARCC icon
251
Ares Capital
ARCC
$14.4B
-696
Closed -$11K
ASH icon
252
Ashland
ASH
$3.5B
-918
Closed -$60K
ASIX icon
253
AdvanSix
ASIX
$444M
-297
Closed -$12K
AUB icon
254
Atlantic Union Bankshares
AUB
$5.97B
-1,359
Closed -$48K
AVNS
255
DELISTED
Avanos Medical
AVNS
-31
Closed -$1K
AXP icon
256
American Express
AXP
$230B
-571
Closed -$52K
BAX icon
257
Baxter International
BAX
$14.2B
-2,040
Closed -$128K
BB icon
258
BlackBerry
BB
$5.26B
-1,373
Closed -$15K
BBN icon
259
BlackRock Taxable Municipal Bond Trust
BBN
$986M
-1,069
Closed -$25K
BBWI icon
260
Bath & Body Works
BBWI
$4.1B
-168
Closed -$6K
BDX icon
261
Becton Dickinson
BDX
$48.2B
-190
Closed -$36K
BEN icon
262
Franklin Resources
BEN
$17.2B
-407
Closed -$18K
BHC icon
263
Bausch Health
BHC
$2.34B
-32
Closed
BKF icon
264
iShares MSCI BIC ETF
BKF
$78.6M
-6
Closed
BKNG icon
265
Booking.com
BKNG
$161B
-150
Closed -$11K
BMRN icon
266
BioMarin Pharmaceuticals
BMRN
$12.4B
-26
Closed -$2K
BNS icon
267
Scotiabank
BNS
$108B
-200
Closed -$13K
BP icon
268
BP
BP
$107B
-1,362
Closed -$47K
BSX icon
269
Boston Scientific
BSX
$71.5B
-238
Closed -$7K
BUD icon
270
AB InBev
BUD
$165B
-79
Closed -$9K
BXP icon
271
Boston Properties
BXP
$11.1B
-1,136
Closed -$140K
BZH icon
272
Beazer Homes USA
BZH
$907M
-3,000
Closed -$56K
C icon
273
Citigroup
C
$226B
-777
Closed -$57K
CABO icon
274
Cable One
CABO
$212M
-25
Closed -$18K
CAH icon
275
Cardinal Health
CAH
$55.4B
-31
Closed -$2K

Similar funds

Alexandria Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Alexandria Capital held 625 positions worth $686M, up 73% from $397M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Alexandria Capital deployed $256M of net new capital in Q4 2017, opening 44 new positions and adding to 123 existing holdings. Its largest new stake was Alnylam Pharmaceuticals: 146,417 shares worth $18.6M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 8.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Morningstar Mega Cap Value ETF, an estimated $678K trimmed.

  • Alexandria Capital's largest Q4 2017 buy was Alnylam Pharmaceuticals: 146,417 shares worth $18.6M.
  • Alexandria Capital added most to Adobe in Q4 2017, an estimated $22.3M increase.
  • Alexandria Capital's biggest Q4 2017 reduction was Vanguard Morningstar Mega Cap Value ETF, cutting an estimated $678K.
  • Alexandria Capital fully exited CoStar Group in Q4 2017, selling an estimated $2.05M.
  • Alexandria Capital's ten largest holdings make up 24% of its $686M portfolio in Q4 2017.
  • Alexandria Capital opened 44 new positions and closed 391 in Q4 2017.
  • Alexandria Capital's portfolio value rose 73% quarter-over-quarter to $686M.

Based on Alexandria Capital's 13F filing for Q4 2017, filed 9 Feb 2018.